Utilizing an A3 project to improve assessment of oral chemotherapy adherence across a five-site enterprise.

136 Background: Cancer Treatment Centers of America, Inc. (CTCA) is a national network of five hospitals that specialize in treating patients fighting complex or advanced-stage cancer. During the fall of 2013, two of the five centers began the pursuit of Quality Oncology Practice Initiative (QOPI) certification. A third site began QOPI certification the spring of 2014 and the remaining two sites followed suit the spring of 2015. This process brought attention to the patient population receiving oral chemotherapy and the importance of careful monitoring of those self-administering their cancer treatment regimens. In July of 2014, before the remaining two sites began the QOPI certification process, an A3 project was introduced to the enterprise, focusing on the assessment of patients’ toxicity and adherence to their oral chemotherapy regimen. The initial data suggested either a lack of documentation or missed opportunity for patient education with baseline performance data at 7.8% across the sites. Methods:...